Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.334 SEK | +1.21% | -13.70% | -62.05% |
09/04 | Biosergen to Issue New Units as Compensation Under Rights Issue | MT |
27/03 | Biosergen Raises SEK26.4 Million via Rights Issue | MT |
Business Summary
Number of employees: 3
Managers
Managers | Title | Age | Since |
---|---|---|---|
Tine Kold Olesen
CEO | Chief Executive Officer | - | - |
Niels Laursen
DFI | Director of Finance/CFO | 68 | - |
Peder Andersen
CTO | Chief Tech/Sci/R&D Officer | 72 | - |
Leila Malik
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 01/21/01 | |
Achim Kaufhold
BRD | Director/Board Member | 66 | 01/21/01 |
Chairman | 65 | 01/15/01 | |
Marianne Kock
BRD | Director/Board Member | 69 | 01/21/01 |
Director/Board Member | 57 | 01/21/01 | |
Director/Board Member | 61 | 01/21/01 | |
Director/Board Member | - | 01/21/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 50,685,863 | 27,820,757 ( 54.89 %) | 0 | 54.89 % |
Company contact information
Sector
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-62.05% | 4.28M | |
-1.93% | 104B | |
+6.84% | 97.47B | |
+5.71% | 22.25B | |
-12.67% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.63% | 16.36B | |
+6.94% | 14.39B | |
+36.13% | 12.37B |
- Stock Market
- Equities
- BIOSGN Stock
- Company Biosergen AB